← Open Payments lookup

KATY FINNEY: Open Payments

NPI 1538545660 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,521 in 64 payments from 13 companies in 2025. Trend: 2023 $944 · 2024 $2,717 · 2025 $2,521

Food & beverage: $2,209Travel & lodging: $313
CompanyPaymentsAmount
Abbott Laboratories14$1,050
Amgen Inc.10$427
Actelion Pharmaceuticals US, Inc.4$196
Boehringer Ingelheim Pharmaceuticals, Inc.13$167
E.R. Squibb & Sons, L.L.C.3$164
Bayer Healthcare Pharmaceuticals Inc.2$153
Novartis Pharmaceuticals Corporation4$101
Boston Scientific Corporation4$84
PFIZER INC.4$71
SCPHARMACEUTICALS INC.3$52

Products named: CARDIOMEMS, JARDIANCE, CAMZYOS, Kerendia, AVEIR, UPTRAVI, LEQVIO, REPATHA.

Industry payments across TX — which companies pay providers there.